Mirizzi Syndrome: Optimal Timing and Management
The American Surgeon™ · 2026
DOI: 10.1177/00031348261441680 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The American Surgeon™, 2026. Verfasst von Rogelio E Molina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Harbor UCLA Medical Center, Torrance, CA, USA. Hauptthemen laut MEDLINE: Mirizzi Syndrome, Cholecystectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Mirizzi syndrome is uncommon with an incidence of 0.3% to 1.4% of all cholecystectomies and remains challenging given the potential need for biliary reconstruction. Standardized surgical guidelines are lacking, which continues to hinder the establishment of optimal operative strategies tailored to disease severity.
Objective
Evaluate postoperative outcomes based on timing of diagnosis (preoperative vs intraoperative), timing of cholecystectomy (index vs delayed), and surgical subspecialty performing the operation.
Methods
A multi-center retrospective review was conducted of all cholecystectomies performed between 2014 and 2023 across 3 Los Angeles County hospitals. Patients with Mirizzi syndrome were identified and stratified according to the Csendes classification. Primary outcomes included bile duct injury, bile leak, biloma, abscess, need for postoperative drainage or reoperation, and readmission. Comparisons were performed using Fisher’s exact test.
Results
Among 14 486 cholecystectomies performed during the study period, 65 patients (0.45%) met inclusion criteria. Complications were significantly lower in patients with preoperative diagnosis compared with intraoperative diagnosis, 25% vs 57% ( P = 0.05). Most patients underwent index-admission cholecystectomy, 52/65 (80%). In advanced disease (types II–Va), complication rates did not differ between index and delayed surgery, 55% vs 38% ( P = 0.67). Overall complication rates were similar between acute care surgery and hepatopancreatobiliary surgery, 24% vs 40% ( P = 0.28). For type I disease, outcomes were comparable between services.
Conclusions
Preoperative diagnosis of Mirizzi syndrome is associated with improved postoperative outcomes. Type I disease can be safely managed by either acute care or hepatopancreatobiliary surgeons, while delayed surgery in advanced cases appears safe to facilitate specialized care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Harbor UCLA Medical Center, Torrance, CA, USA.
ORCID-Profile: Rogelio E Molina
Zitieren
APA
Molina, R. E., Rosenberg, D. M., Burrows, J. E., Kim, J. J., Petrovich, K. A., Eade, A. V., Garcia, L., & Keeley, J. A. (2026). Mirizzi Syndrome: Optimal Timing and Management. The American Surgeon™. https://doi.org/10.1177/00031348261441680
Vancouver
Molina RE, Rosenberg DM, Burrows JE, Kim JJ, Petrovich KA, Eade AV, et al. Mirizzi Syndrome: Optimal Timing and Management. The American Surgeon™. 2026. doi:10.1177/00031348261441680
BibTeX
@article{Molina2026,
author = {Molina, Rogelio E and Rosenberg, David M and Burrows, Julia E and Kim, Jane J and Petrovich, Katherine A and Eade, Alyssa V and Garcia, Lorena and Keeley, Jessica A},
title = {Mirizzi Syndrome: Optimal Timing and Management},
journal = {The American Surgeon™},
year = {2026},
doi = {10.1177/00031348261441680}
}
EUVIMED